Reason for request
Inclusion of the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
In the absence of data relating to pre-treated patients whose characteristics are different from those observed at baseline in the DUET-1 and DUET-2 studies, INTELENCE offers no improvement in actual benefit (level V). |
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
KU3dUw5HLtRQHkeG
